A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.

导出 LinkOut

翻译打印收藏纠错

作者： Zhenbin,Wei ^[1] ; Gaohui,Yang ^[1] ; Yumei,Huang ^[1] ; Peng,Peng ^[2] ; Liling,Long ^[2] ; Yuan,Long ^[1] ; Xiaoping,Huang ^[1] ; Xuemei,Zhou ^[1] ; Yongrong,Lai ^[1] ; Rongrong,Liu ^[1]

作者单位： Department of Hematology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China. ^[1] Department of Radiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China. ^[2]

关键词 deferasirox iron chelation therapy iron overload long-term follow-up β thalassemia major

主题词随访研究(Follow-Up Studies);人类(Humans);铁螯合剂(Iron Chelating Agents);铁超负荷(Iron Overload);预后(Prognosis);治疗结果(Treatment Outcome);β地中海贫血(beta-Thalassemia)

DOI 10.1111/bjh.17035

PMID 32945527

发布时间 2021-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交